NCT00056966
- Conditions
- Anemia, Anemia, Aplastic, Blood Protein Disorders, +35 more
- Locations
-
- Texas Children's Hospital Houston, Texas, United States
- The Methodist Hospital Houston, Texas, United States
Clinical trial condition
Hematologic Malignancy
Explore clinical trials studying Hematologic Malignancy. Study availability and eligibility vary by location and protocol.
166 public trials
63 recruiting studies
Hematologic Malignancy trial results
NCT00476177
- Conditions
- Graft vs Host Disease, Hematologic Diseases, Hematologic Malignancy, +5 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Completed
CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation
NCT00333190
- Conditions
- ALL, AML, Blood Protein Disorders, +24 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Active, Not Recruiting
Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity
NCT03890614
- Conditions
- Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +3 more
- Locations
-
- Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States
Active, Not Recruiting
Technology to Assess Vulnerable Older Adults With Cancer and Their Caregivers
NCT02041416
- Conditions
- Cancer, Hematologic Diseases, Hematologic Malignancy, +5 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, Not Recruiting
Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasia
NCT03431090
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +9 more
- Locations
-
- Nationwide Children's Hospital Columbus, Ohio, United States
Active, Not Recruiting
A Positive Psychology Based Intervention (PATH-C) for Caregivers of HSCT Survivors
NCT06153797
- Conditions
- Caregiver, Hematologic Diseases, Hematologic Malignancy, +4 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Active, Not Recruiting
Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation
NCT04395222
- Conditions
- Bone Marrow Transplant, Hematologic Diseases, Hematologic Malignancy, +4 more
- Locations
-
- Weill Cornell Medical College New York, United States
Active, Not Recruiting
CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After All-HSCT
NCT06449586
- Conditions
- Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +3 more
- Locations
-
- Tongji Hospital of Huazhong University of Science and Technology, Wuhan Wuhan, Hubei, China
- Ruijin Hospital of Shanghai Jiaotong University Shanghai, Shanghai Municipality, China
- The First Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China
- Ruijin Hospital, Shanghai JiaoTong University School of Medicine Shanghai, China
Active, Not Recruiting
Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant
NCT05709912
- Conditions
- Bone Marrow Transplant Complications, Hematologic Diseases, Hematologic Malignancy, +4 more
- Locations
-
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States